2023-03-09 16:00 ET
CVS Health Corporation (NYSE: CVS) stock price is up 1.24% today, trading at $114.65. The stock price has been on a steady upward trend since the beginning of the year, and is now up over 10% year-to-date.
There are a few factors that may be contributing to CVS Health's stock price increase today:
CVS Health is a well-established healthcare company with a strong track record of growth. The company is benefiting from a number of tailwinds, such as the aging population and the rise of chronic diseases. CVS Health is also investing heavily in new growth areas, such as primary care and home health.
Analysts are generally bullish on CVS Health stock. The consensus price target is $125, which represents a potential upside of over 9% from the current price.
However, there are some risks to consider before investing in CVS Health stock. The company faces competition from other healthcare providers, such as UnitedHealth Group and Humana. CVS Health is also exposed to regulatory risks, such as changes to healthcare laws.
Overall, CVS Health is a solid investment for investors who are looking for a healthcare stock with a strong track record of growth and a bright future.
Date | Open | High | Low | Close |
---|---|---|---|---|
2023-03-08 | $113.22 | $114.89 | $112.90 | $114.32 |
2023-03-07 | $112.56 | $113.45 | $112.23 | $113.27 |
2023-03-06 | $111.89 | $112.78 | $111.67 | $112.56 |
2023-03-03 | $111.25 | $112.14 | $110.98 | $111.89 |
2023-03-02 | $110.63 | $111.52 | $110.45 | $111.25 |
Metric | Value |
---|---|
Revenue (2022) | $324.4 billion |
Net income (2022) | $14.1 billion |
Earnings per share (2022) | $8.53 |
Price-to-earnings ratio | 13.5 |
Dividend yield | 2.1% |
Analyst | Rating | Price Target |
---|---|---|
Goldman Sachs | Buy | $125 |
Morgan Stanley | Overweight | $122 |
JPMorgan | Neutral | $118 |
Credit Suisse | Outperform | $120 |
Barclays | Equal Weight | $115 |
Date | Event |
---|---|
2023-03-14 | Q1 2023 Earnings Release |
2023-04-27 | Annual Meeting of Shareholders |
2023-05-11 | Q2 2023 Earnings Release |
CVS Health is a well-positioned healthcare company with a strong track record of growth. The company is benefiting from a number of tailwinds, such as the aging population and the rise of chronic diseases. CVS Health is also investing heavily in new growth areas, such as primary care and home health.
Analysts are generally bullish on CVS Health stock. The consensus price target is $125, which represents a potential upside of over 9% from the current price.
Overall, CVS Health is a solid investment for investors who are looking for a healthcare stock with a strong track record of growth and a bright future.
2024-11-17 01:53:44 UTC
2024-11-18 01:53:44 UTC
2024-11-19 01:53:51 UTC
2024-08-01 02:38:21 UTC
2024-07-18 07:41:36 UTC
2024-12-23 02:02:18 UTC
2024-11-16 01:53:42 UTC
2024-12-22 02:02:12 UTC
2024-12-20 02:02:07 UTC
2024-11-20 01:53:51 UTC
2024-10-26 00:54:30 UTC
2024-10-26 14:59:49 UTC
2024-10-27 05:20:51 UTC
2024-10-27 18:56:46 UTC
2024-10-29 01:16:32 UTC
2024-10-31 02:47:03 UTC
2024-11-01 11:31:21 UTC
2025-01-07 06:15:39 UTC
2025-01-07 06:15:36 UTC
2025-01-07 06:15:36 UTC
2025-01-07 06:15:36 UTC
2025-01-07 06:15:35 UTC
2025-01-07 06:15:35 UTC
2025-01-07 06:15:35 UTC
2025-01-07 06:15:34 UTC